numer
infecti
agent
respons
caus
primari
secondari
respiratori
diseas
dog
agent
caus
upper
lower
respiratori
infect
commonli
observ
veterinari
practic
clinic
sign
might
vari
mild
dyspnea
sneez
cough
sever
pneumonia
system
manifest
depend
etiolog
agent
gross
microscop
chang
observ
infect
rather
unspecif
highli
characterist
pattern
histopatholog
cytolog
alway
requir
diagnosi
respiratori
infect
often
use
establish
definit
diagnosi
identifi
specif
etiolog
agent
research
regard
epidemiolog
pathogenesi
diagnost
clinic
manifest
relat
infecti
pathogen
provid
valuabl
inform
improv
treatment
manag
diseas
caus
review
discuss
epidemiolog
gener
clinic
characterist
patholog
lesion
import
viral
bacteri
fungal
parasit
etiolog
canin
respiratori
diseas
respiratori
tract
constantli
expos
infecti
agent
reach
upper
lower
respiratori
tract
aerogen
hematogen
invas
respiratori
tract
deleteri
pathogen
normal
prevent
physic
chemic
immunolog
mechan
includ
mucu
mucociliari
clearanc
variou
innat
antimicrobi
factor
alveolar
macrophag
pulmonari
immun
respons
respiratori
pathogen
caus
infect
secondari
opportunist
invad
host
defens
mechan
disrupt
factor
eg
immunosuppress
environ
stress
toxin
concurr
infect
also
primari
pathogen
develop
mechan
virul
factor
enabl
disrupt
evad
host
defens
without
predispos
factor
regardless
whether
agent
affect
upper
lower
respiratori
tract
host
respons
vari
base
sever
infect
pathogen
mechan
pathogen
immun
statu
host
thu
morpholog
chang
similarli
vari
mild
circulatori
chang
mucos
pulmonari
edema
congest
sever
mucos
pulmonari
inflamm
patholog
chang
impair
normal
homeostasi
manifest
clinic
respiratori
dysfunct
clinic
identif
infecti
agent
challeng
sinc
respiratori
sign
unspecif
vari
mild
unproduct
cough
sever
pneumonia
accompani
system
chang
current
numer
diagnost
tool
avail
identif
respiratori
agent
develop
molecular
diagnost
tool
allow
rapid
identif
wide
varieti
pathogen
establish
accur
treatment
howev
diagnosi
respiratori
diseas
still
often
base
histori
clinic
sign
radiographi
cytolog
bacteri
cultur
histopatholog
rare
use
diagnost
tool
practic
lower
respiratori
infect
howev
nasal
biopsi
commonli
use
identif
agent
affect
upper
respiratori
tract
due
potenti
complic
associ
collect
procedur
biopsi
lung
histopatholog
less
frequent
util
etiolog
diagnosi
instead
morpholog
chang
commonli
evalu
cytolog
still
histopatholog
specimen
obtain
necropsi
consid
best
resourc
pathogenesi
studi
situ
detect
agent
associ
local
chang
review
discuss
gener
specif
morpholog
chang
pathogenesi
clinic
sign
treatment
import
viral
bacteri
fungal
parasit
caus
infecti
respiratori
diseas
dog
fungal
rhiniti
commonli
caus
ubiquit
soil
fungi
notabl
aspergillu
fumigatu
rare
penicillium
spp
young
middl
age
dolichocephal
mesaticephal
dog
present
sign
includ
mucopurul
discharg
initi
unilater
sneez
epistaxi
nasal
depigment
ulcer
stertor
stridor
variabl
present
advanc
case
facial
deform
may
appreci
without
lacrim
duct
obstruct
epiphora
known
fumigatu
caus
diseas
small
proport
dog
whether
diseas
result
higher
exposur
fungi
suppress
normal
nasal
defens
fungal
organ
clear
innat
immun
system
invas
requir
adher
penetr
respiratori
epithelium
destruct
surround
cell
resist
phagocytosi
lack
fungal
invas
mucos
tissu
adjac
bone
argu
system
immun
dysfunct
predomin
helper
cellmedi
immun
respons
seem
effect
prevent
system
dissemin
fungu
howev
effect
clear
infect
nasal
caviti
persist
infect
may
due
defect
local
defens
mechan
local
immun
respons
unexplain
increas
may
play
role
local
immun
dysfunct
impair
antifung
function
phagocyt
secret
proinflammatori
cytokin
protect
cellmedi
immun
function
may
benefici
resolut
inflammatori
respons
infect
clear
may
detriment
fulmin
mycot
infect
invas
bone
usual
limit
nasal
turbin
subsequ
destruct
caus
combin
host
immun
respons
dermonecrolyt
fungal
toxin
variou
virul
factor
studi
vitro
may
contribut
diseas
interf
innat
host
defens
howev
signific
pathogenesi
canin
nasal
diseas
known
def
init
diagnosi
best
achiev
direct
visual
rhinoscopi
endoscopi
follow
microscop
examin
scrape
biopsi
fungal
plaqu
lesion
often
surround
hyperem
edemat
mucosa
purul
exud
caseou
debri
andor
hemorrhag
nasal
caviti
destruct
distort
nasal
turbin
vari
mild
sever
fungal
plaqu
appear
white
dull
usual
flat
irregular
mass
sit
mucos
surfac
cover
mucopurul
exud
figur
fungal
coloni
sometim
form
upright
spheric
structur
becom
grayish
black
form
solid
sheet
materi
cover
larg
portion
nasal
caviti
histopatholog
reveal
ulcer
mucosa
cover
plaqu
necrot
tissu
admix
fibrin
underli
lamina
propria
heavili
infiltr
lymphocyt
plasma
cell
fewer
macrophag
mild
case
may
mild
infiltr
neutrophil
fungal
organ
rare
ever
observ
invad
mucosa
instead
found
superfici
necrot
plaqu
free
materi
within
nasal
caviti
dens
accumul
nonpig
septat
hypha
branch
dichotom
angl
system
treatment
oral
antifung
typic
efficaci
sole
therapi
medic
expens
associ
side
effect
includ
hepatotox
anorexia
vomit
instead
treatment
focus
topic
antifung
treatment
may
supplement
system
antifung
local
therapi
instil
topic
antifung
clotrimazol
enilconazol
nasal
sinus
prefer
distribut
retent
antifung
therapi
within
nasal
caviti
sinus
vari
prolong
drugcontact
time
reduc
anesthet
durat
research
investig
use
antifung
cream
instead
suspens
nasal
sinus
act
local
depot
drug
therapi
nasal
diseas
may
rare
caus
rhinosporidium
seeberi
aquat
protistan
parasit
mesomycetozoa
famili
refer
drip
dermocystidium
rosett
agent
ichthyophonu
psorospermium
clade
develop
matur
endospor
stimul
water
exposur
therefor
agent
associ
wet
environ
parasit
endem
india
sri
lanka
argentina
sporad
case
report
canada
unit
kingdom
itali
unit
state
major
case
report
unit
state
southeastern
south
central
state
extend
far
north
missouri
clinic
sign
includ
wheez
sneez
unilater
seropurul
nasal
discharg
epistaxi
possibl
visibl
mass
within
nare
exposur
contamin
water
histori
trauma
suggest
predispos
factor
author
suggest
hunt
roam
dog
increas
risk
due
increas
exposur
factor
animaltoanim
animaltohuman
transmiss
document
could
explain
recent
research
suggest
multipl
hostspecif
strain
typic
lesion
singl
unilater
nasal
polyp
characterist
strawberri
appear
soft
pink
bleed
easili
pinpoint
white
foci
repres
matur
sporangia
may
visibl
grossli
nasal
scrape
smear
prefer
fineneedl
aspir
sinc
lesion
tend
bleed
demonstr
intact
spherul
endospor
free
within
sporangia
diagnost
howev
sporangia
often
seen
cytolog
exfoli
readili
altern
histopatholog
excision
biopsi
therapeut
diagnost
show
polyploid
prolifer
submucosa
hyperplasia
metaplasia
overli
epithelium
granulomat
pyogranulomat
inflamm
sporangia
variou
stage
matur
figur
endospor
round
eosinophil
magenta
basophil
bodi
diamet
intern
eosinophil
globul
thick
wall
stain
may
help
identifi
endospor
includ
toluidin
blue
period
acidschiff
reaction
methenamin
wright
gridley
prefer
method
treatment
nasal
rhinosporidiosi
surgic
excis
lesion
howev
report
slowli
progress
recurr
surgeri
treatment
includ
system
ketoconazol
dapson
howev
drug
often
associ
side
effect
limit
inform
regard
efficaci
canin
patient
nonspecif
infecti
rhiniti
nonspecif
infecti
rhiniti
rare
dog
commonli
occur
secondari
nasal
trauma
allergi
inhal
foreign
materi
clinic
sign
includ
sneez
cough
waterymuc
suppur
nasal
discharg
depend
sever
infect
sign
may
accompani
fever
lethargi
anorexia
specif
agent
associ
clinic
present
although
canin
parainfluenza
viru
canin
adenoviru
type
bordetella
bronchiseptica
commonli
isol
agent
morpholog
chang
nonspecif
includ
mucos
hyperemia
swell
edema
fluid
glandular
secret
histolog
chang
vari
upon
sever
chronic
diseas
initi
minim
balloon
degener
nasal
epithelium
accompani
ciliari
loss
submucos
edema
occasion
infiltr
lymphocyt
plasma
cell
sever
case
secondari
bacteri
invas
mucosa
infiltr
neutrophil
necrosi
desquam
epithelium
chronic
stage
lamina
propria
thicken
abund
fibrou
connect
tissu
mucos
gland
atrophi
epitheli
dysplasia
predispos
factor
commonli
unknown
treatment
target
manag
nonspecif
respiratori
symptom
secondari
bacteri
infect
dog
respiratori
infect
typic
upper
airway
diseas
refer
laryngotrach
infecti
tracheobronch
itb
infecti
respiratori
diseas
complex
kennel
cough
diseas
highli
contagi
character
inflamm
upper
respiratori
tract
mani
case
itb
involv
viral
bacteri
pathogen
numer
agent
isol
commonli
identifi
etiolog
agent
includ
canin
parainfluenza
viru
b
bronchiseptica
secondari
agent
canin
herpesviru
canin
reoviru
type
bacteria
streptococcu
spp
pasteurella
spp
pseudomona
spp
coliform
mycoplasma
often
report
recent
report
implic
involv
unusu
agent
streptococcu
equi
subspeci
zooepidemicu
andor
mycoplasma
cyno
either
alon
associ
predispos
viral
agent
part
multietiolog
complex
new
virus
also
emerg
novel
pathogen
canin
respiratori
tract
includ
canin
influenza
viru
civ
group
canin
coronaviru
canin
pantrop
coronaviru
group
canin
coronaviru
canin
respiratori
coronaviru
pneumoviru
howev
role
pathogen
caus
itb
still
debat
pathogen
normal
transmit
cough
sneez
nosetonos
contact
dog
dens
hous
ie
shelter
day
care
center
board
kennel
veterinari
hospit
occurr
clinic
sign
due
high
number
pathogen
dens
hous
environ
inadequ
sanitari
condit
import
factor
popul
densiti
ventil
sanit
staff
train
also
play
role
moreov
anim
facil
rapid
anim
turnov
high
percentag
young
anim
may
immunocompromis
due
poor
complet
lack
passiv
immun
anim
shelter
demonstr
diseas
differ
epidemiolog
pattern
compar
dog
household
infect
establish
shelter
quickli
reach
high
morbid
rate
normal
clinic
sign
selflimit
howev
predispos
condit
overpopul
immun
defici
clinic
present
might
vari
sever
fatal
lesion
within
upper
respiratori
tract
vari
appar
normal
airway
hyperemia
mucopurul
exud
depend
sever
infect
secondari
bacteri
involv
inconsist
associ
lymphoid
tissu
tonsil
retropharyng
tracheal
lymph
node
moder
enlarg
histolog
chang
confin
trachea
bronchi
character
initi
lymphoplasmacyt
infiltr
lamina
propria
accompani
interstiti
edema
capillari
hyperemia
necrosi
epithelium
uncommon
secretori
gland
hyperplast
sever
case
tracheal
bronchial
lumen
occlud
abund
mucoid
materi
intermix
neutrophil
bacteri
coloni
histolog
chang
rather
unspecif
histopatholog
rare
use
diagnost
techniqu
moreov
etiolog
diagnosi
uncommon
sinc
larg
number
pathogen
frequent
interact
andor
overlap
thu
common
diagnost
routin
base
presenc
clinic
sign
treatment
itb
symptomat
howev
due
common
occurr
secondari
infect
broad
spectrum
bacteria
antibiot
treatment
first
therapeut
approach
antibiot
select
base
cultur
sensit
test
airway
specimen
collect
transtrach
aspir
bronchoscopi
antibiot
commonli
use
amoxicillinclavulan
acid
cephalexin
clindamycin
azithromycin
antibiot
reach
effect
concentr
tracheobronchi
mucosa
well
pulmonari
parenchyma
bacteri
infect
sever
anim
respond
parenter
antibiot
aerosol
kanamycin
sulfat
gentamicin
sulfat
shown
reduc
b
bronchiseptica
number
distal
trachea
bronchi
order
amelior
clinic
sign
itb
cough
suppress
bronchodil
recommend
antituss
codein
deriv
hydrocodon
butorphanol
use
control
persist
nonproduct
cough
even
though
itb
normal
caus
bronchial
hyperactivityspasm
bronchodil
theophyllin
aminophyllin
may
use
prevent
bronchospasm
therefor
act
effect
cough
suppress
usual
clinic
sign
sever
affect
dog
present
anorexia
howev
acut
phase
prolong
sever
case
support
care
maintain
adequ
calor
fluid
intak
may
necessari
current
vaccin
agent
associ
itb
agent
respons
itb
canin
distemp
viru
includ
core
vaccin
main
goal
core
vaccin
protect
anim
lifethreaten
diseas
global
distribut
howev
world
small
anim
veterinari
associ
defin
core
vaccin
shelterh
dog
high
densiti
popul
expos
differ
environ
compar
household
thu
vaccin
guidelin
group
world
small
anim
veterinari
associ
defin
core
vaccin
shelterh
dog
must
includ
canin
distemp
viru
canin
parvoviru
type
intranas
b
bronchiseptica
canin
parainfluenza
viru
use
civ
includ
recommend
noncor
vaccin
shelter
dog
howev
benefit
vaccin
limit
exposur
prevent
least
week
second
immun
number
viral
agent
implic
case
report
lower
respiratori
diseas
bulk
clinic
recogn
viral
pneumonia
attribut
three
virus
canin
distemp
viru
canin
parainfluenza
viru
pure
viral
pneumonia
character
nonspecif
interstiti
pattern
thorax
open
lung
fail
collaps
diffus
red
gray
meati
wet
rib
impress
may
note
viscer
pleural
surfac
minim
visibl
exud
within
airspac
unless
secondari
bacteri
pneumonia
develop
histolog
chang
observ
earli
stage
nonspecif
mostli
associ
circulatori
chang
congest
hyperemia
small
mediums
capillari
infect
progress
chang
character
thicken
alveolar
septa
interstiti
edema
lymphocyt
plasma
cell
occasion
macrophag
alveoli
line
hyperplast
type
ii
pneumocyt
pulmonari
fibrosi
occur
result
chronic
interstiti
pneumonia
clinic
present
pure
viral
pneumonia
rare
sinc
viral
infect
normal
impair
pulmonari
defens
inevit
result
secondari
bacteri
infect
bronchopneumonia
base
exud
observ
later
stage
diseas
bacteri
bronchopneumonia
classifi
suppur
fibrin
howev
sinc
exud
coexist
morpholog
differenti
rather
difficult
suppur
bronchopneumonia
histolog
character
bronchial
bronchiolar
alveolar
lumina
fill
numer
neutrophil
macrophag
fibrin
occasion
area
hemorrhag
treatment
target
manag
clinic
sign
secondari
bacteri
infect
similar
describ
itb
howev
sever
case
dog
could
need
oxygen
supplement
mechan
ventil
epidemiolog
pathogenesi
specif
etiolog
agent
well
studi
review
therefor
newli
emerg
concern
mention
independ
abil
produc
diseas
higher
mortal
rate
expect
typic
itb
pneumonia
civ
consid
emerg
diseas
fairli
recent
histori
sinc
studi
confirm
dog
could
experiment
infect
human
prior
influenza
consid
specif
canin
diseas
dog
also
consid
reservoir
influenza
maintain
influenza
subtyp
could
transmit
influenza
viru
dog
first
interspeci
transmiss
equin
strain
describ
greyhound
popul
florida
diseas
becom
widespread
current
affect
state
unit
state
today
consid
major
threat
dog
dens
hous
first
report
unit
state
sever
studi
demonstr
interspeci
transmiss
numer
countri
unit
kingdom
serolog
immunohistochem
molecular
retrospect
studi
link
outbreak
respiratori
diseas
english
foxhound
equin
influenza
viru
equin
influenza
outbreak
australia
presenc
influenza
viru
dog
close
contact
equin
influenza
virusinfect
hors
confirm
convers
attempt
prove
presenc
influenza
canada
show
one
dog
serolog
posit
evalu
dog
present
primari
care
veterinari
clinic
dog
previous
contact
race
track
texa
influenza
viru
compos
eight
separ
strand
ribonucl
acid
code
eleven
protein
classifi
subtyp
base
two
superfici
antigen
hemagglutinin
neuraminidas
protein
differ
type
hemagglutinin
nine
neuraminidas
antigen
sequenc
analysi
civ
indic
strain
nucleotid
sequenc
ident
equin
influenza
viru
first
report
influenza
dog
associ
infect
describ
highli
contagi
respiratori
diseas
high
morbid
reach
low
mortal
howev
first
report
within
florida
greyhound
popul
mortal
rate
reach
strain
involv
canin
infect
serolog
report
south
korea
demonstr
high
antibodi
preval
later
survey
perform
china
demonstr
strain
observ
korea
also
respons
sporad
case
china
addit
studi
reveal
respiratori
diseas
sever
kennel
south
korea
also
caus
strain
homolog
influenza
strain
avian
origin
infect
caus
mild
transient
respiratori
diseas
interspeci
transmiss
high
pathogen
avian
influenza
viru
also
report
dog
dog
sever
respiratori
sign
report
thailand
dog
die
sever
day
ingest
duck
carcass
region
outbreak
high
pathogen
avian
influenza
viru
describ
phylogenet
analysi
reveal
viru
isol
dog
close
relat
high
pathogen
avian
influenza
viru
recov
virus
avian
influenza
outbreak
period
despit
numer
studi
demonstr
dog
epitheli
receptor
necessari
viral
attach
upper
lower
respiratori
tract
dogtodog
transmiss
could
demonstr
contact
anim
unlik
influenza
viru
canineadapt
influenza
viru
capabl
dogtodog
dogtocat
transmiss
caus
respiratori
diseas
speci
two
clinic
present
describ
dog
civ
infect
milder
transient
respiratori
diseas
common
present
resembl
itb
diseas
character
initi
fever
follow
sneez
ocular
discharg
cough
purul
nasal
discharg
resolv
day
infect
peracuteand
fatal
present
character
mainli
sever
pulmonari
pleural
mediastin
hemorrhag
may
result
secondari
bacteri
infect
histolog
chang
normal
accompani
civ
infect
rather
nonspecif
vari
mild
tracheiti
bronchiti
bronchiol
suppur
bronchopneumonia
nevertheless
lesion
insuffici
make
specif
diagnosi
requir
complementari
diagnosi
viral
isol
polymeras
chain
reaction
immunohistochemistri
serolog
pathogenesi
civ
vari
significantli
influenza
subtyp
affect
mammal
viru
replic
epitheli
cell
upper
lower
respiratori
tract
caus
epitheli
necrosi
follow
neutrophil
infiltr
later
infiltr
airway
mononuclear
inflammatori
cell
later
stage
type
ii
alveolar
hyperplasia
alveolar
macrophag
respons
product
tumor
necrosi
import
proinflammatori
cytokin
establish
acut
inflammatori
respons
appear
clinic
sign
although
clear
pulmonari
sourc
lymphocyt
macrophag
experiment
evid
cytokin
play
import
role
increas
suscept
bacteri
pneumonia
follow
influenza
infect
specif
ic
treatment
civ
infect
antibiot
import
treat
secondari
bacteri
infect
commonli
associ
civ
infect
recombin
equin
vaccin
express
hemagglutinin
equin
shown
reduc
clinic
sign
viru
shed
dog
challeng
recent
isol
civ
commerci
vaccin
civ
subtyp
condit
approv
unit
state
depart
agricultur
fulli
licens
june
inactiv
vaccin
proven
control
civ
clinic
sign
reduc
sever
associ
pulmonari
lesion
well
viral
shed
coinfect
trial
equi
subspeci
zooepidemicu
vaccin
significantli
reduc
clinic
sign
given
risk
profil
necessari
civ
infect
similar
dog
expos
kennel
cough
vaccin
may
use
dog
vaccin
b
bronchiseptica
parainfluenza
canin
respiratori
coronaviru
first
detect
unit
kingdom
trachea
lung
tissu
dog
viru
close
relat
human
bovin
coronavirus
distinct
canin
enter
coronaviru
respiratori
coronaviru
widespread
north
america
japan
sever
european
countri
seropreval
vari
unit
state
japan
diseas
particularli
kennel
dog
popul
viru
detect
revers
transcriptasepolymeras
chain
reaction
asymptomat
symptomat
dog
suffer
mild
moder
respiratori
diseas
role
canin
respiratori
coronaviru
itb
clear
like
infect
viru
induc
subclin
mild
respiratori
diseas
coronaviru
associ
upper
respiratori
diseas
also
capabl
damag
respiratori
epithelium
predispos
bacteri
infect
canin
pantrop
coronaviru
first
describ
itali
sever
fatal
outbreak
report
around
europ
outbreak
character
high
mortal
young
anim
sever
organ
includ
gastrointestin
tract
nervou
system
respiratori
system
affect
postmortem
examin
show
extens
lobar
bronchopneumonia
compromis
cranial
caudal
lobe
along
effus
thorac
caviti
viral
isol
character
reveal
presenc
coronaviru
type
contain
point
mutat
chang
cellular
tropism
viru
current
vaccin
cross
protect
gastrointestin
coronaviru
streptococcu
spp
streptococcu
spp
opportunist
pathogen
upper
respiratori
tract
equi
subspeci
zooepidemicu
import
pathogen
hors
pig
recent
link
case
acut
fatal
pneumonia
dog
sever
countri
numer
report
describ
outbreak
acut
hemorrhag
pneumonia
character
high
morbid
high
mortal
reach
current
insuffici
data
determin
pathogenesi
equi
subspeci
zooepidemicu
dog
howev
sever
factor
host
suscept
coinfect
presenc
three
superantigen
gene
szef
szen
szep
propos
contributor
rapid
onset
diseas
fast
deterior
mani
dog
infect
equi
subspeci
zooepidemicu
high
level
proinflammatori
cytokin
tumor
necrosi
observ
acut
infect
suggest
pulmonari
lesion
result
cytokin
storm
acut
respiratori
distress
syndrom
pneumon
lesion
appear
within
hour
postinfect
character
rubberi
mottl
dark
bright
red
lung
accompani
sever
hemothorax
area
collaps
singl
studi
unit
kingdom
differ
pneumon
pattern
observ
fibrinosuppur
necrot
hemorrhag
fibrin
hemorrhag
fibrinosuppur
common
histopatholog
find
includ
sever
suppur
hemorrhag
bronchopneumonia
character
diffus
alveolar
neutrophil
infiltr
abund
hemorrhag
edema
larg
chain
coloni
gram
posit
bacteria
occasion
pulmonari
lesion
accompani
necrosuppur
bronchiti
tracheiti
due
acut
sever
clinic
sign
intraven
antibiot
treatment
choic
clinic
isol
seem
sensit
follow
antimicrobi
agent
cefalotin
amoxicillinclavulan
acid
tetracyclin
trimethoprimsulfadiazin
enrofloxacin
marbofloxacin
penicillin
g
antibiot
sensit
profil
becom
import
issu
sinc
human
acquir
infect
canin
case
fungal
infect
may
manifest
primari
pneumonia
system
diseas
dissemin
lung
organ
clinic
sign
lower
respiratori
tract
infect
includ
cough
tachypnea
dyspnea
exercis
intoler
addit
dissemin
may
report
clinic
manifest
refer
affect
organ
system
blastomyc
dermatitidi
histoplasma
capsulatum
coccidioid
immiti
primari
fungal
pathogen
involv
canin
pneumonia
b
dermatitidi
exist
mold
saprophyt
phase
sandi
acid
soil
near
water
character
hypha
produc
conidiophor
spheric
oval
conidia
fungu
endem
basin
mississippi
ohio
st
lawrenc
river
north
america
also
found
canada
africa
india
dog
higher
risk
infect
highli
involv
outdoor
activ
often
includ
year
old
male
intact
medium
heavi
weight
hound
sport
dog
spore
produc
myceli
growth
inhal
enter
termin
airway
transform
yeast
parasit
phase
reproduc
broadbas
singl
bud
b
dermatitidi
quickli
dissemin
organ
vascular
lymphat
vessel
case
lung
lesion
resolv
time
clinic
sign
refer
affect
organ
aris
h
capsulatum
dimorph
fungu
exist
mold
saprophyt
phase
temperatur
character
septat
hypha
microconidia
macroconidia
fungu
endem
temper
subtrop
region
case
unit
state
occur
river
valley
ohio
missouri
mississippi
river
fungal
particl
microconidia
macroconidia
inhal
deposit
lower
respiratori
tract
transform
yeast
parasit
phase
virul
factor
h
capsulatum
allow
organ
enter
surviv
within
phagocyt
subsequ
dissemin
monocyterich
organ
earli
cours
diseas
c
immiti
mold
soil
saprophyt
phase
made
hypha
secondari
branch
chain
infecti
arthroconidia
region
distribut
fungu
primarili
lower
sonoran
life
zone
includ
area
southwestern
unit
state
arizona
utah
new
mexico
nevada
texa
mexico
central
south
america
tissu
parasit
phase
arthroconidia
grow
spheric
sporangia
spherul
produc
hundr
endospor
veterinarian
within
endem
region
report
clinic
ill
seem
occur
commonli
young
adult
dog
addit
dog
spent
time
outdoor
land
roam
expos
dusti
environ
endem
area
increas
risk
infect
dissemin
occur
nearli
tissu
creat
wide
rang
clinic
sign
outsid
respiratori
tract
dog
chronic
complaint
respiratori
diseas
lame
andor
neurolog
sign
also
travel
histori
endem
area
within
past
year
c
immiti
infect
suspect
clinic
sign
histori
physic
examin
imag
lead
strong
clinic
suspicion
mycot
diseas
howev
treatment
expens
sometim
caus
side
effect
definit
diagnosi
identif
organ
often
warrant
perform
togeth
cytolog
histopatholog
cultur
approach
specif
nearli
depend
expertis
pathologist
laboratori
diagnosi
often
made
cytolog
examin
transtrach
wash
bronchoalveolar
lavag
fluid
fineneedl
aspir
parenchym
lesion
organ
locat
within
interstitium
bronchoalveolar
lavag
like
recov
organ
identif
although
transtrach
wash
less
invas
safer
procedur
regardless
etiolog
lung
typic
contain
multipl
tangray
variabl
size
nodul
scatter
throughout
blastomycosi
nodul
contain
pyogranuloma
granuloma
occasion
contain
extens
central
caseou
necrosi
thin
rim
macrophag
number
intralesion
yeast
bodi
variabl
within
extens
inflamm
often
miss
routin
hematoxylin
eosin
stain
particularli
antifung
therapi
partial
immun
initi
yeast
round
diamet
distinct
doublecontour
wall
thick
granular
protoplasm
complet
partli
fill
center
occasion
display
singl
broadbas
bud
figur
rare
filament
pseudohyph
form
conidia
identifi
histoplasmosi
nodul
character
microscop
granulomat
inflamm
contain
epithelioid
macrophag
mani
contain
numer
h
capsulatum
organ
multinucl
giant
cell
fewer
neutrophil
plasma
cell
lymphocyt
h
capsulatum
organ
numer
intracellular
diamet
round
bodi
basophil
center
light
halo
occasion
narrowbas
bud
figur
organ
often
identifi
within
macrophag
sometim
neutrophil
rectal
scrape
imprint
colon
biopsi
periton
pleural
effus
rare
cerebrospin
fluid
rare
h
capsulatum
identifi
circul
neutrophil
eosinophil
coccidioidomycosi
initi
reaction
primarili
suppur
lesion
develop
pyogranuloma
granuloma
character
epithelioid
macrophag
giant
cell
lymphocyt
neutrophil
spherul
larg
round
doublewal
structur
figur
contain
numer
endospor
may
numer
within
microabscess
lesion
promin
suppur
howev
chronic
case
littl
neutrophil
inflamm
organ
present
may
found
engulf
giant
cell
case
period
acidschiff
gridley
fungal
gomori
methenamin
stain
may
need
help
identifi
organ
treatment
fungal
pneumonia
mainli
involv
use
azol
drug
itraconazol
ketoconazol
fluconazol
andor
amphotericin
b
itraconazol
prefer
treatment
b
dermatitidi
h
capsulatum
infect
gener
itraconazol
treatment
b
dermatitidi
patient
administ
least
day
least
month
resolut
clinic
sign
h
capsulatum
month
treatment
itraconazol
usual
suffici
higher
initi
load
dose
may
requir
sever
clinic
sign
itraconazol
treatment
expens
easier
administ
caus
fewer
side
effect
compar
amphotericin
b
hope
lower
treatment
cost
one
studi
compar
fluconazol
itraconazol
found
similar
efficaci
howev
fluconazol
often
requir
longer
treatment
period
obtain
clinic
remiss
fluconazol
sometim
use
case
ocular
central
nervou
system
involv
excel
water
solubl
allow
penetr
bloodbrain
bloodocular
barrier
although
ketoconazol
cheaper
drug
side
effect
commonli
report
ketoconazol
drug
choic
c
immiti
infect
requir
length
administr
may
extend
least
year
dissemin
diseas
bone
involv
amphotericin
b
use
conjunct
azol
therapi
case
sever
fulmin
pulmonari
gastrointestin
diseas
associ
h
capsulatum
infect
refractori
case
rapid
onset
action
administr
intraven
risk
nephrotox
use
lower
cumul
dose
amphotericin
b
follow
cours
ketoconazol
use
amphotericin
b
lipid
complex
onetenth
toxic
tradit
amphotericin
b
report
safer
effect
altern
newer
drug
investig
treatment
fungal
infect
includ
chitin
synthas
inhibitor
nikkomycin
z
caspofungin
terbinafin
naftifin
analog
newer
azol
voriconazol
posaconazol
advoc
addit
use
antiinflammatori
dose
glucocorticoid
order
decreas
secondari
inflamm
associ
death
fungal
organ
reduc
airway
obstruct
hilar
lymphadenopathi
chronic
case
howev
clear
benefit
alway
appreci
recommend
order
avoid
dissemin
parasit
respiratori
diseas
four
metastrongyloid
nematod
caus
respiratori
diseas
dog
osleru
osleri
crenosoma
vulpi
filaroid
hirthi
filaroid
andersonstrongylu
milksi
preval
lungworm
infect
presum
low
base
fecal
examin
studi
howev
diagnost
techniqu
bear
limit
may
underestim
number
true
case
osleri
inhabit
distal
trachea
tracheal
bifurc
firstdivis
bronchi
within
granulomat
nodul
mucos
surfac
life
cycl
direct
transmiss
occur
saliva
dam
pup
matern
groom
regurgit
food
ingest
contamin
fece
infect
may
subclin
caus
chronic
cough
sometim
exacerb
exercis
tracheal
palpat
uncommonli
infect
may
present
acut
dyspnea
subacut
diseas
character
intermitt
difficulti
breath
cough
visual
rais
nodul
near
tracheal
bifurc
bronchoscopi
figur
addit
recoveri
firststag
larva
bronchial
mucu
fece
provid
definit
diagnosi
nodul
contain
coil
adult
within
space
often
dilat
lymphat
surround
loos
connect
tissu
mark
inflamm
compos
plasma
cell
neutrophil
eosinophil
figur
tail
femal
worm
sometim
evid
success
therapi
osleri
base
cessat
larval
output
resolut
clinic
sign
clearanc
tracheal
bronchial
nodul
success
report
treatment
includ
extend
oral
administr
benzimidazol
fenbendazol
thiabendazol
oxfendazol
offlabel
use
macrocycl
lacton
ivermectin
doramectin
subcutan
surgeri
debulk
larg
obstruct
mass
may
consid
howev
usual
necessari
nodul
regress
medic
therapi
c
vulpi
also
inhabit
trachea
bronchi
bronchiol
caus
chronic
bronchitisbronchiol
character
chronic
cough
wild
canid
fox
coyot
domest
canid
serv
definit
host
firststag
larva
pass
fece
cough
swallow
subsequ
infect
terrestri
snail
slug
serv
intermedi
host
infect
acquir
ingest
intermedi
host
definit
diagnosi
base
detect
firststag
larva
fece
transtrach
wash
sampl
comparison
osleri
c
vulpi
found
often
within
bronchi
endoscop
accompani
erythema
mucoid
discharg
hyperplast
nodul
success
treatment
commonli
achiev
oral
fenbendazol
howev
administr
febantel
milbemycin
oxim
levamisol
diethylcarbamazin
also
use
f
hirthi
f
milksi
similar
parasit
alveoli
termin
airway
caus
multifoc
interstiti
pneumon
life
cycl
f
milksi
unknown
transmiss
f
hirthi
ingest
firststag
larva
fece
coprophagi
infect
usual
subclin
howev
dog
especi
immunosuppress
may
present
acut
chronic
cough
dyspnea
definit
diagnosi
made
detect
firststag
larva
bronchial
mucu
fece
find
necropsi
gener
consid
incident
includ
wide
scatter
subpleur
graytan
blackgreen
diamet
nodul
may
clear
cystic
center
white
firm
microscop
larva
typic
incit
acut
suppur
respons
littl
respons
live
worm
within
alveoli
howev
worm
dead
degener
mark
granulomat
eosinophil
inflamm
worm
fragment
clear
may
residu
foci
granulomat
interstiti
pneumonia
differenti
f
hirthi
f
milksi
possibl
histopatholog
section
treatment
f
hirthi
includ
oral
administr
fenbendazol
day
oral
albendazol
repeat
week
later
report
unit
state
canada
variou
countri
europ
recent
interest
grown
due
zoonot
potenti
potenti
expand
distribut
europ
specul
due
global
warm
life
cycl
direct
ova
produc
adult
bronchi
cough
swallow
pass
fece
ova
requir
approxim
day
matur
excret
remain
viabl
soil
year
ova
may
also
matur
within
earthworm
act
facult
intermedi
host
although
import
transmiss
fulli
elucid
infect
subclin
dog
may
present
chronic
cough
sever
sign
dyspnea
weight
loss
secondari
bacteri
pneumonia
rare
occur
diagnosi
base
identif
doubleopercul
yellowbrown
ova
fecal
examin
cytolog
evalu
airway
specimen
differenti
c
aerophila
ova
trichuri
vulpi
import
base
smaller
size
asymmetr
bipolar
plug
anastomos
network
ridg
within
wall
worm
slender
cm
long
resid
white
coil
mass
embed
tracheobronchi
mucosa
incit
mild
catarrh
bronchiti
occasion
embryon
egg
associ
worm
research
report
treatment
limit
howev
fenbendazol
report
success
paragonimiasi
uncommon
diseas
caus
trematod
fluke
infest
lung
dog
mammal
speci
paragonimu
describ
worldwid
endem
asia
america
africa
two
import
speci
includ
p
westermani
wide
distribut
speci
p
kellicotti
endem
north
america
life
cycl
indirect
requir
two
intermedi
host
egg
pass
fece
definit
mammalian
host
hatch
miracidium
infect
aquat
snail
first
intermedi
host
develop
snail
parasit
infect
second
intermedi
host
crayfish
direct
penetr
ingest
snail
infect
dog
acquir
ingest
crayfish
follow
migrat
parasit
intestin
lung
resid
pair
within
fibrou
subpleur
cyst
bulla
commun
bronchiol
adult
produc
ova
cough
swallow
pass
fece
complet
lifecycl
clinic
sign
often
limit
chronic
cough
exercis
intoler
howev
sever
dyspnea
may
occur
cyst
ruptur
pneumothorax
definit
diagnosi
base
identif
characterist
egg
bronchial
mucu
fece
fineneedl
aspir
lung
nodul
nodul
may
seen
radiograph
earli
week
postinfect
comput
tomographi
examin
day
postinfect
egg
typic
oval
yellowbrown
opercul
thicken
ridg
shell
wall
along
line
operculum
postmortem
examin
reveal
spheric
diamet
soft
dark
redbrown
nodul
within
caudal
lung
lobe
contain
one
two
fluke
thick
brown
fluid
microscop
cavit
contain
mark
eosinophil
granulomat
inflamm
hemorrhag
numer
hemosiderinladen
macrophag
adult
fluke
fibrou
capsul
figur
patent
infect
also
numer
ova
within
lesion
cavit
matur
becom
true
cyst
incorpor
bronchiolar
tree
line
cuboid
epithelium
bronchiol
may
contain
ova
eosinophil
exud
addit
hyperplasia
peribronchiolar
gland
smooth
muscl
variabl
chronic
catarrh
eosinophil
bronchiol
granulomat
pleuriti
pleural
lymphang
occur
effect
treatment
p
kellicotti
dog
includ
oral
administr
praziquantel
fenbendazol
albendazol
exact
taxonom
classif
pneumocysti
carinii
debat
characterist
consist
fungi
protozoan
recogn
structur
form
organ
cyst
intracyst
sporozoit
trophozoit
cyst
thickwal
spheric
ovoid
crescentshap
um
diamet
contain
eight
pleomorph
sporozoit
trophozoit
thinwal
um
diamet
appear
extracyst
form
sporozoit
clinic
case
pneumonia
caus
p
carinii
dog
attribut
suspect
document
concurr
cellmedi
immunodefici
preexist
pulmonari
diseas
sporad
case
clinic
diseas
report
associ
stress
crowd
immunosuppress
therapi
glucocorticoid
chemotherapi
irradi
concurr
canin
distemp
infect
definit
diagnosi
base
direct
visual
organ
respiratori
fluid
biopsi
specimen
amplif
dna
sampl
lower
respiratori
tract
grossli
lung
firm
consolid
pale
brown
gray
collaps
upon
open
thorac
caviti
microscop
alveoli
fill
aggreg
amorph
foami
eosinophil
materi
macrophag
detach
alveolar
line
cell
grocott
methenamin
silver
stain
often
use
help
identifi
cyst
stage
organ
neutrophil
absent
littl
phagocytosi
intact
organ
alveolar
septa
may
thicken
dens
accumul
plasma
cell
lymphocyt
macrophag
fibrosi
chronic
infect
pentamid
isethion
combin
trimethoprim
sulfonamid
use
success
treatment
pneumocystosi
drug
use
includ
carbutamid
trimetrex
combin
clindamycin
primaquin
dapson
trimethoprim
symptomat
therapi
often
concurr
initi
includ
oxygen
administr
mucolyt
bronchodil
nebul
discontinu
immunosuppress
medic
modern
vaccin
manag
strategi
decreas
respiratori
diseas
domest
dog
within
household
respiratori
infect
still
major
concern
high
densiti
hous
situat
area
vaccin
proper
anim
manag
husbandri
practic
implement
situat
allow
infect
persist
propag
potenti
spread
popul
research
classic
respiratori
condit
dog
discuss
herein
enabl
develop
treatment
diagnost
prevent
strategi
infect
howev
still
mani
unansw
question
regard
pathogenesi
immunopatholog
characterist
infecti
agent
may
provid
inform
pertin
develop
specif
treatment
definit
diagnost
prevent
strategi
author
report
conflict
interest
work
